Cyberounds Logo
October 22, 2019 | LOGIN | REGISTER | HELP | 
email a friend print Bookmark and Share
Progestins and the Brain
CME credit is no longer available for this conference.
Muye Zhu, B.S., and Roberta Diaz Brinton, Ph.D.

Ms. Zhu is a doctoral candidate, Neuroscience Program, College of Letters, Arts and Sciences, University of Southern California and Dr. Brinton is Professor of Pharmacology and Pharmaceutical Sciences, Biomedical Engineering and Neurology, School of Pharmacy, Viterbi USC School of Engineering and Keck USC School of Medicine, University of Southern California, Los Angeles, CA.

Within the past 12 months, Ms. Zhu and Dr. Brinton report no commercial conflicts of interest.

Albert Einstein College of Medicine, CCME staff, and interMDnet staff have nothing to disclose.


Release Date: 12/01/2011
Termination Date: 12/01/2014

Estimated time to complete: 1 hour(s).

Albert Einstein College of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Albert Einstein College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
 
Learning Objectives
Upon completion of this Cyberounds®, you should be able to:
  • Discuss the differential effects of progestins on the regenerative (neurogenic) capacity of the brain
  • Discuss the contrasting effects on brain metabolism induced by progesterone and medroxyprogesterone
  • Discuss the clinical implications of progestin regulation of brain regeneration, metabolism and white matter generation
  • Apply their understanding of the effects of long-term exposure to progestins on brain function and the chronic use of hormone therapies and contraceptives.

 
The opinions expressed herein are those of the authors and do not necessarily represent the views of the sponsor or its publisher. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.
 
Please click below to accept the terms of this CME activity